<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0410538" disease_type="Disease or Syndrome" abbrv="PSACH">Pseudoachondroplasia</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e>) and <z:hpo ids='HP_0002655'>spondyloepiphyseal dysplasia</z:hpo> congenita (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEDC</z:e>) are <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> forms of short-limb <z:hpo ids='HP_0004322'>short stature</z:hpo> caused by mutations in genes that encode structural components of the cartilage extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> results from mutations in the cartilage oligomeric matrix protein (COMP) gene, while <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEDC</z:e> is caused by mutations in the gene for type II procollagen (COL2A1) </plain></SENT>
<SENT sid="2" pm="."><plain>We report a child with a distinct <z:hpo ids='HP_0002652'>skeletal dysplasia</z:hpo> due to the combined phenotypes of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEDC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The proband's mother had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> and his father had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEDC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The child was suspected of having both phenotypes on the basis of the severity of his clinical and radiographic findings, and this was confirmed by molecular analysis </plain></SENT>
<SENT sid="5" pm="."><plain>The COMP gene mutation (C348R), while not previously published, is typical of those in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PSACH</z:e> patients, whereas the COL2A1 mutation (T1370M) is somewhat atypical, as it predicts an amino acid change within the carboxyl-terminal region of the protein </plain></SENT>
<SENT sid="6" pm="."><plain>Both mutations segregated with their respective phenotypes within this family </plain></SENT>
<SENT sid="7" pm="."><plain>The description and natural history of the double heterozygote phenotype may be useful in counseling families regarding risk and prognosis </plain></SENT>
</text></document>